Compounds > cefoperazone
Page last updated: 2024-08-23

cefoperazone and piperacillin, tazobactam drug combination

cefoperazone has been researched along with piperacillin, tazobactam drug combination in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (5.00)29.6817
2010's13 (65.00)24.3611
2020's6 (30.00)2.80

Authors

AuthorsStudies
Das, BK; Dhawan, B; Kapil, A; Mohanty, S; Singhal, R; Sood, S1
Emecen, M; Erdem, E; Karaman, S; Kebudi, R; Vural, S; Yildirmak, Y1
Anjum, R; Fahim, Q; Gill, MM; Hassan, A; Kaleem, F; Khalid, A; Usman, J1
Afridi, FI; Farooqi, BJ1
Boral, OB; Cağatay, P; Keçeli, SA; Sonmez, N; Tamer, GS; Willke, A1
Bosnak, VK; Karaoglan, I; Mete, AO; Namiduru, M; Zer, Y1
Arda, B; Nazli-Zeka, A; Ozkoren-Calik, S; Pullukcu, H; Sipahi, H; Sipahi, OR; Tasbakan, M; Ulusoy, S; Yamazhan, T1
Lai, J; Li, S; Liang, L; Peng, B; Wang, Z; Zheng, J1
Araya, I; Contreras, S; Fasce, G; Hurtado, V; Núñez, E; Opazo, JL; Quiñones, LA; Saez, E1
Aynioglu, A; Hacihanefioglu, A; Mutlu, B1
Ji, JS; Quan, JJ; Wang, HP; Wang, Y; Wang, YF; Xu, YC; Yu, YS1
Gao, L; Li, Y; Lyu, Y1
Hao, D; Hu, Z; Liu, X; Sun, T; Tian, H; Wang, T; Wang, X1
Ejaz, A; Ejaz, H; Javed, H; Saleem, R; Younas, S; Zafar, A1
Guclu, E; Karabay, O; Kaya, G; Ogutlu, A1
Chen, CH; Chen, CM; Chen, WC; Fang, WF; Fu, PK; Huang, CT; Ku, SC; Kuo, LK; Lai, CC; Tu, CY; Wang, YT1
Chang, Q; Ding, L; He, X; Huang, W; Li, X; Wan, X1
Easow, JM; S, P; S, S; S, U1
Chen, CH; Chen, CM; Chen, WC; Cheng, WC; Fang, WF; Fu, PK; Ku, SC; Kuo, LK; Lai, CC; Tu, CY; Wang, YT1

Trials

2 trial(s) available for cefoperazone and piperacillin, tazobactam drug combination

ArticleYear
Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia.
    Pediatric blood & cancer, 2012, Volume: 58, Issue:4

    Topics: Adolescent; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Time Factors

2012
A comparison of the efficacy of piperacillin-tazobactam and cefoperazone-sulbactam therapies in the empirical treatment of patients with febrile neutropenia.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2016, Volume: 29, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Cefoperazone; Drug Combinations; Drug Eruptions; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Leukocyte Count; Male; Middle Aged; Neutrophils; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sulbactam; Treatment Outcome; Young Adult

2016

Other Studies

18 other study(ies) available for cefoperazone and piperacillin, tazobactam drug combination

ArticleYear
Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria.
    The Indian journal of medical research, 2005, Volume: 122, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acids; Cross Infection; Gram-Negative Bacteria; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Ticarcillin

2005
Frequency and antibiogram of multi-drug resistant Pseudomonas aeruginosa.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2011, Volume: 21, Issue:9

    Topics: Anti-Bacterial Agents; Cefoperazone; Colistin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam

2011
Activity of beta-lactam beta-lactamase inhibitor combinations against extended spectrum Beta-lactamase producing Enterobacteriaceae in urinary isolates.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2012, Volume: 22, Issue:6

    Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acids; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sensitivity and Specificity; Sulbactam; Urinary Tract Infections

2012
Interaction between caspofungin or voriconazole and cefoperazone-sulbactam or piperacillin-tazobactam by in vitro and in vivo methods.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2014, Volume: 122, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Candida albicans; Candidiasis; Caspofungin; Cefoperazone; Drug Interactions; Echinocandins; Female; Lipopeptides; Mice; Mice, Inbred BALB C; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyrimidines; Sulbactam; Triazoles; Voriconazole

2014
In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    The Journal of international medical research, 2013, Volume: 41, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Carbapenems; Cefoperazone; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Tigecycline

2013
Piperacillin/tazobactam vs. cefoperazone/sulbactam in adult low-risk febrile neutropenia cases.
    International journal of clinical practice, 2014, Volume: 68, Issue:2

    Topics: Anti-Bacterial Agents; Cefoperazone; Drug Combinations; Febrile Neutropenia; Female; Humans; Male; Middle Aged; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Sulbactam; Treatment Outcome

2014
[Experimental study on concentrations and pharmacokinetics of antibiotics in bile and evaluation of their microbicidal potential].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 2014, Volume: 52, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Bile; Cefoperazone; Drug Combinations; Meropenem; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rabbits; Random Allocation; Sulbactam; Thienamycins

2014
A Non-inferiority Pilot Study Comparing the Clinical Efficacy and Safety of Generic Wide-spectrum Antibiotic Use in Septic Oncology Patients.
    Drug research, 2015, Volume: 65, Issue:12

    Topics: Administration, Intravenous; Anti-Bacterial Agents; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drugs, Generic; Female; Humans; Imipenem; Male; Middle Aged; Oncology Service, Hospital; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Sepsis; Sulbactam; Treatment Outcome

2015
[The activity of moxalactam against Enterobacteriaceae and anaerobia in vitro].
    Zhonghua yi xue za zhi, 2016, May-17, Volume: 96, Issue:18

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Cefoperazone; Enterobacteriaceae; Escherichia coli; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Moxalactam; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus; Thienamycins

2016
Trends in Drug Resistance of
    Chinese medical journal, 2017, Mar-20, Volume: 130, Issue:6

    Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Cefepime; Cefoperazone; Ceftazidime; Cephalosporins; China; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam

2017
[Analysis of the distribution characteristics and drug resistance of non-fermenting bacterial infection in intensive care unit from 2009 to 2015]
    Zhonghua wei zhong bing ji jiu yi xue, 2016, Volume: 28, Issue:5

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cefoperazone; Cephalosporins; Cross Infection; Drug Resistance; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Retrospective Studies; Thienamycins

2016
AmpC beta-lactamases in Klebsiella pneumoniae: An emerging threat to the paediatric patients.
    JPMA. The Journal of the Pakistan Medical Association, 2018, Volume: 68, Issue:6

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefoperazone; Cefoxitin; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Pakistan; Piperacillin, Tazobactam Drug Combination; Sulbactam

2018
The effect of cefoperazone sulbactam and piperacillin tazobactam on mortality in Gram-negative nosocomial infections.
    Journal of chemotherapy (Florence, Italy), 2020, Volume: 32, Issue:3

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sulbactam

2020
P1-6: Clinical effectiveness of cefoperazone-sulbactam versus piperacillin-tazobactam for the treatment of pneumonia in the elderly population.
    Respirology (Carlton, Vic.), 2021, Volume: 26 Suppl 3

    Topics: Aged; Anti-Bacterial Agents; Cefoperazone; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Pneumonia; Sulbactam; Treatment Outcome

2021
Clinical effectiveness of cefoperazone-sulbactam vs. piperacillin-tazobactam for the treatment of pneumonia in elderly patients.
    International journal of antimicrobial agents, 2022, Volume: 59, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefoperazone; Cohort Studies; Community-Acquired Infections; Female; Frail Elderly; Healthcare-Associated Pneumonia; Humans; Male; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated; Retrospective Studies; Sulbactam; Treatment Outcome

2022
Cross-reactivity between piperacillin-tazobactam and cefoperazone-sulbactam in drug-induced immune thrombocytopenia.
    The Journal of international medical research, 2023, Volume: 51, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Cefoperazone; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Purpura, Thrombocytopenic, Idiopathic; Sulbactam

2023
Antibiotic Susceptibility Pattern of Aerobic Bacterial Pathogen Isolated from Endotracheal Aspirate.
    The Journal of the Association of Physicians of India, 2022, Volume: 70, Issue:12

    Topics: Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Pseudomonas aeruginosa

2022
The clinical efficacy of cefoperazone-sulbactam versus piperacillin-tazobactam in the treatment of severe community-acquired pneumonia.
    Medicine, 2023, Jul-14, Volume: 102, Issue:28

    Topics: Anti-Bacterial Agents; Cefoperazone; Community-Acquired Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Retrospective Studies; Sulbactam; Treatment Outcome

2023